Arama Sonuçları - Cheng Ean Chee
- Gösterilen 1 - 17 sonuçlar arası kayıtlar. 17
-
1
Making sense of adjuvant chemotherapy in colorectal cancer Yazar: Gloria Chan, Cheng Ean Chee
Baskı/Yayın Bilgisi 2019Revisão -
2
Autophagy modulation for cancer therapy Yazar: Zhineng J. Yang, Cheng Ean Chee, Shengbing Huang, Frank A. Sinicrope
Baskı/Yayın Bilgisi 2011Revisão -
3
The Role of Autophagy in Cancer: Therapeutic Implications Yazar: Zhineng J. Yang, Cheng Ean Chee, Shengbing Huang, Frank A. Sinicrope
Baskı/Yayın Bilgisi 2011Revisão -
4
-
5
Rational drug combination design in patient-derived avatars reveals effective inhibition of hepatocellular carcinoma with proteasome and CDK inhibitors Yazar: Jhin Jieh Lim, Lissa Hooi, Yock Young Dan, Glenn Kunnath Bonney, Lei Zhou, Pierce K. H. Chow, Cheng Ean Chee, Tan Boon Toh, Edward Kai‐Hua Chow
Baskı/Yayın Bilgisi 2022Artigo -
6
PIPAC-OX: A Phase I Study of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy in Patients with Peritoneal Metastases Yazar: Guowei Kim, Hon Lyn Tan, Raghav Sundar, Bettina Lieske, Cheng Ean Chee, Jingshan Ho, Asim Shabbir, Maria V. Babak, Wee Han Ang, Boon Cher Goh, Wei Peng Yong, Lingzhi Wang, Jimmy Bok Yan So
Baskı/Yayın Bilgisi 2020Artigo -
7
Dynamic, personalized dose selection platform, CURATE.AI, in patients with solid tumors: case series and pilot feasibility trial Yazar: Raghav Sundar, Agata Blasiak, Anh T. L. Truong, Lester W. J. Tan, Kirthika Senthil Kumar, Shi‐Bei Tan, Chong Boon Teo, Benjamin Y. L. Tan, Xavier Tadeo, Hon Lyn Tan, Cheng Ean Chee, Wei Peng Yong, Dean Ho
Baskı/Yayın Bilgisi 2024Pré-impressão -
8
Phase II Study of Dasatinib (BMS-354825) in Patients With Metastatic Adenocarcinoma of the Pancreas Yazar: Cheng Ean Chee, Smitha Krishnamurthi, Charles Nock, Neal J. Meropol, Joseph Gibbons, Pingfu Fu, Joseph A. Bokar, Lois Teston, Timothy O'Brien, Vinay Gudena, Amy Reese, Mark Bergman, Joel Saltzman, James R. Wright, Afshin Dowlati, Joanna M. Brell
Baskı/Yayın Bilgisi 2013Artigo -
9
Updated efficacy and safety of entrectinib in NTRK fusion-positive non-small cell lung cancer Yazar: Byoung Chul Cho, Chao‐Hua Chiu, Erminia Massarelli, Gary L. Buchschacher, Kōichi Goto, Tobias R. Overbeck, Herbert H. Loong, Cheng Ean Chee, Pilar Garrido, Xiaorong Dong, Yun Fan, Shun Lü, Sven Schwemmers, Walter Bordogna, Harald Zeuner, Stuart Osborne, Thomas John
Baskı/Yayın Bilgisi 2023Artigo -
10
Analysis and Validation of Human Targets and Treatments Using a Hepatocellular Carcinoma–Immune Humanized Mouse Model Yazar: Yue Zhao, Jiaxu Wang, Wai Nam Liu, Shin Yie Fong, Timothy Wai Ho Shuen, Min Liu, Sarah Harden, Sue Yee Tan, Jia Ying Cheng, Wilson Wei Sheng Tan, Jerry Kok Yen Chan, Cheng Ean Chee, Guan Huei Lee, Han Chong Toh, Seng Gee Lim, Yue Wan, Qingfeng Chen
Baskı/Yayın Bilgisi 2021Artigo -
11
Clinical relevance of PD-1 positive CD8 T-cells in gastric cancer Yazar: Joan Choo, Ley Fang Kua, Mu Yar Soe, Bernadette Reyna Asuncion, Benjamin Kye Jyn Tan, Chong Boon Teo, Ryan Yong Kiat Tay, Jimmy Bok Yan So, Asim Shabbir, Kim Guowei, Hon Lyn Tan, Gloria Chan, Haoran Ma, Gokula Krishnan Ramachandran, Jeffrey Lum, Cheng Ean Chee, Sriram Sridharan, Patrick Tan, Raghav Sundar, Wei Peng Yong
Baskı/Yayın Bilgisi 2023Artigo -
12
Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy Yazar: Yue Zhao, Timothy Wai Ho Shuen, Tan Boon Toh, Xue Ying Chan, Min Liu, Sue Yee Tan, Yong Fan, Hechuan Yang, Shridhar Ganpathi Lyer, Glenn Kunnath Bonney, Eva Loh, Kenneth Tou En Chang, Thiam Chye Tan, Weiwei Zhai, Jerry Kok Yen Chan, Edward Kai‐Hua Chow, Cheng Ean Chee, Guan Huei Lee, Yock Young Dan, Pierce K. H. Chow, Han Chong Toh, Seng Gee Lim, Qingfeng Chen
Baskı/Yayın Bilgisi 2018Artigo -
13
Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma Yazar: Ronan J. Kelly, Jeeyun Lee, Yung‐Jue Bang, Khaldoun Almhanna, Mariela Blum‐Murphy, Daniel V.T. Catenacci, Hyun Cheol Chung, Zev A. Wainberg, Michael K. Gibson, Keun‐Wook Lee, Johanna C. Bendell, Crystal S. Denlinger, Cheng Ean Chee, Takeshi Omori, Rom S. Leidner, Heinz‐Josef Lenz, Yee Chao, Marlon C. Rebelatto, Philip Z. Brohawn, Peng He, Jennifer McDevitt, Siddharth Sheth, Judson M. Englert, Geoffrey Y. Ku
Baskı/Yayın Bilgisi 2019Artigo -
14
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer Yazar: Takayuki Yoshino, Guillem Argilés, Eiji Oki, Erika Martinelli, Hiroya Taniguchi, Dirk Arnold, Saori Mishima, Yongjun Li, BK Smruti, Joong Bae Ahn, I. Faud, Cheng Ean Chee, Kun‐Huei Yeh, Pin‐Wen Lin, C. Chua, Harissa Husainy Hasbullah, M.A. Lee, Atul Sharma, Yan Sun, Giuseppe Curigliano, Hideaki Bando, Florian Lordick, Takeharu Yamanaka, Josep Tabernero, Eishi Baba, Andrés Cervantes, Atsushi Ohtsu, Solange Peters, Chikashi Ishioka, George Pentheroudakis
Baskı/Yayın Bilgisi 2021Artigo -
15
Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer Yazar: Ayumi Hashimoto, Debashis Sarker, Vikash Reebye, Sheba Jarvis, Mikael H. Sodergren, Andrew V. Kossenkov, Emilio Sanseviero, Nina Raulf, Jenni Vasara, Pinelopi Andrikakou, Tim Meyer, Kai‐Wen Huang, Ruth Plummer, Cheng Ean Chee, Duncan Spalding, Madhava Pai, Shahid A. Khan, David J. Pinato, Rohini Sharma, Bristi Basu, Daniel H. Palmer, Yuk Ting, JEFF EVANS, Robert Habib, Աննա Մարտիրոսյան, Naouel Elasri, Adeline Reynaud, John J. Rossi, Mark Cobbold, Nagy Habib, Dmitry I. Gabrilovich
Baskı/Yayın Bilgisi 2021Artigo -
16
PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein Yazar: Min Thura, Abdul Qader Al-Aidaroos, Abhishek Gupta, Cheng Ean Chee, Soo Chin Lee, Kam M. Hui, Jie Li, Yeoh Khay Guan, Wei Peng Yong, Jimmy Bok Yan So, Wee Joo Chng, Chin Hin Ng, Jianbiao Zhou, Ling Zhi Wang, John Shyi Peng Yuen, Henry Sun Sien Ho, Mei Yi Sim, Edmund Chiong, Su Pin Choo, Joanne Ngeow, Matthew Chau Hsien Ng, Clarinda Chua, Eugene Shen Ann Yeo, Iain Bee Huat Tan, Joel Sng, Nicholas Yan Zhi Tan, Jean Paul Thiery, Boon Cher Goh, Qi Zeng
Baskı/Yayın Bilgisi 2019Artigo -
17
MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial Yazar: Debashis Sarker, Ruth Plummer, Tim Meyer, Mikael H. Sodergren, Bristi Basu, Cheng Ean Chee, Kai‐Wen Huang, Daniel H. Palmer, Yuk Ting, T.R. Jeff Evans, Duncan Spalding, Madhava Pai, Rohini Sharma, David J. Pinato, James Spicer, Sarah Hunter, Vineet Kwatra, Joanna P. Nicholls, D Michael Collin, Robert Nutbrown, Helen Glenny, Sonia Fairbairn, Vikash Reebye, Jon Voutila, Stephanie Dorman, Pinelopi Andrikakou, Peter Lloyd, Steve Felstead, Jenni Vasara, Robert Habib, Chris B. Wood, Pål Sætrom, Hans E. Huber, David C. Blakey, John J. Rossi, Nagy Habib
Baskı/Yayın Bilgisi 2020Artigo
Arama Araçları:
İlgili Konular
Medicine
Internal medicine
Cancer
Biology
Oncology
Cancer research
Biochemistry
Gastroenterology
Immunology
Immunotherapy
Chemotherapy
Colorectal cancer
Immune system
Adverse effect
Apoptosis
Genetics
Surgery
Autophagy
CEBPA
Cancer cell
Capecitabine
Cell biology
Cell cycle
Clinical trial
Gene
Hepatocellular carcinoma
Oxaliplatin
Pathology
Pharmacology
Programmed cell death